Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation

The ability of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) to maintain virologic suppression in participants with M184V and/or M184I resistance mutations from historical genotypic reports when switching from a tenofovir disoproxil fumarate–based or abacavir (ABC)-based re...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Acquir Immune Defic Syndr
Main Authors: Perez-Valero, Ignacio, Llibre, Josep M., Castagna, Antonella, Pulido, Federico, Molina, Jean-Michel, Esser, Stefan, Margot, Nicolas, Shao, Yongwu, Temme, Lauren, Piontkowsky, David, McNicholl, Ian R., Haubrich, Richard
Format: Artigo
Sprog:Inglês
Udgivet: JAIDS Journal of Acquired Immune Deficiency Syndromes 2021
Fag:
Clinical Science
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899215/
https://ncbi.nlm.nih.gov/pubmed/33315694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002595
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker